GlaxoSmithKline Notice of First Quarter Results Announcement and Teleconference

Apr 20, 2001, 01:00 ET from GlaxoSmithKline plc

    PHILADELPHIA, April 20 /PRNewswire Interactive News Release/ -- On
 Tuesday, 24th April 2001, GlaxoSmithKline plc (NYSE:   GSK) will announce its
 First Quarter results for the 3 months ended 31st March 2001. The announcement
 will be released to the New York Stock Exchange at approximately 7:30 a.m.
 EDT.
     Following the announcement, JP Garnier, Chief Executive Officer; Robert
 Ingram, Chief Operating Officer & President, Pharmaceutical Operations; and
 John Coombe, Chief Financial Officer; will hold a media teleconference where
 you will be able to listen to a presentation of the First Quarter results,
 and participate in a Q&A session afterwards.
 
     The media telephone conference will take place on:
 
                   Tuesday, 24th April 2001 at 8:15 a.m. EDT
 
     The telephone number you will need to call is:
 
                        (212) 271-4758 or (800) 865-0780
 
            (If you should have difficulty connecting to this number
                       please call:  011 44 141 626 0226)
 
     A replay of the media teleconference will be available from 11:30 a.m. EDT
 until 30th April at the following number:
 
            (858) 812 - 6440 or (800) 633 - 8284, Passcode 18541855#
 
     Following the media teleconference at 9:30 a.m. will be a teleconference
 for analysts/investors.  Media interested in listening to that teleconference
 should dial:
 
                                 (888) 209-3792
 
     A recording of the analyst/investor teleconference will be available from
 11:15 a.m. EDT on 24th April until 30th April on telephone number:
 
              (858) 812-6440 or (800) 633-8284, Passcode 18542100#
 
     The full announcement as well as a slide presentation will be available
 from 7:30 a.m. EDT on Tuesday, 24th April, on the GlaxoSmithKline Internet
 site: http://corp.gsk.com
 
 
     Media enquiries:
                              Nancy Pekarek   (215) 751-7709
                              Mary Anne Rhyne (919) 483-2839
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X75138865
 
 

SOURCE GlaxoSmithKline plc
    PHILADELPHIA, April 20 /PRNewswire Interactive News Release/ -- On
 Tuesday, 24th April 2001, GlaxoSmithKline plc (NYSE:   GSK) will announce its
 First Quarter results for the 3 months ended 31st March 2001. The announcement
 will be released to the New York Stock Exchange at approximately 7:30 a.m.
 EDT.
     Following the announcement, JP Garnier, Chief Executive Officer; Robert
 Ingram, Chief Operating Officer & President, Pharmaceutical Operations; and
 John Coombe, Chief Financial Officer; will hold a media teleconference where
 you will be able to listen to a presentation of the First Quarter results,
 and participate in a Q&A session afterwards.
 
     The media telephone conference will take place on:
 
                   Tuesday, 24th April 2001 at 8:15 a.m. EDT
 
     The telephone number you will need to call is:
 
                        (212) 271-4758 or (800) 865-0780
 
            (If you should have difficulty connecting to this number
                       please call:  011 44 141 626 0226)
 
     A replay of the media teleconference will be available from 11:30 a.m. EDT
 until 30th April at the following number:
 
            (858) 812 - 6440 or (800) 633 - 8284, Passcode 18541855#
 
     Following the media teleconference at 9:30 a.m. will be a teleconference
 for analysts/investors.  Media interested in listening to that teleconference
 should dial:
 
                                 (888) 209-3792
 
     A recording of the analyst/investor teleconference will be available from
 11:15 a.m. EDT on 24th April until 30th April on telephone number:
 
              (858) 812-6440 or (800) 633-8284, Passcode 18542100#
 
     The full announcement as well as a slide presentation will be available
 from 7:30 a.m. EDT on Tuesday, 24th April, on the GlaxoSmithKline Internet
 site: http://corp.gsk.com
 
 
     Media enquiries:
                              Nancy Pekarek   (215) 751-7709
                              Mary Anne Rhyne (919) 483-2839
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X75138865
 
 SOURCE  GlaxoSmithKline plc